Literature DB >> 21693628

Biomarkers related to one-carbon metabolism as potential risk factors for distal colorectal adenomas.

Stefan de Vogel1, Jörn Schneede, Per Magne Ueland, Stein Emil Vollset, Klaus Meyer, Ase Fredriksen, Øivind Midttun, Tone Bjørge, Ellen Kampman, Michael Bretthauer, Geir Hoff.   

Abstract

BACKGROUND: Efficient one-carbon metabolism, which requires adequate supply of methyl group donors and B-vitamins, may protect against colorectal carcinogenesis. However, plasma folate and vitamins B2 and B12 have inconsistently been associated with colorectal cancer risk, and there have been no previous studies relating plasma concentrations of methionine, choline, and betaine to this outcome.
METHODS: This study comprised 10,601 individuals, 50 to 64 years of age, participating in the Norwegian Colorectal Cancer Prevention (NORCCAP) screening study. Using logistic regression analyses, we crosssectionally investigated associations between distal colorectal adenoma occurrence-potential precursor lesions of colorectal carcinomas-and plasma concentrations of methyl group donors and B-vitamins, and polymorphisms of genes related to one-carbon metabolism.
RESULTS: Screening revealed 1,809 subjects (17.1%) with at least one adenoma. The occurrence of high-risk adenomas (observed in 421 subjects) was inversely associated with plasma concentrations of methionine (highest versus lowest quartile: odds ratio (OR) = 0.61; 95% confidence interval (CI) = 0.45-0.83), betaine: OR = 0.74; 95% CI = 0.54-1.02, the vitamin B2 form flavin-mononucleotide (FMN): OR = 0.65; 95% CI = 0.49-0.88, and the vitamin B6 form pyridoxal 5'-phosphate (PLP): OR = 0.69; 95% CI = 0.51-0.95, but not with folate, choline, vitamin B12 concentrations, or with the studied polymorphisms. High methionine concentration in combination with high vitamin B2 or B6 concentrations was associated with lower occurrence of high-risk adenomas compared with these factors individually.
CONCLUSIONS: High plasma concentrations of methionine and betaine, and vitamins B2 and B6 may reduce risk of developing colorectal adenomas. IMPACT: In addition to B-vitamins, methyl group donors such as methionine and betaine may play a role in colorectal carcinogenesis. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21693628     DOI: 10.1158/1055-9965.EPI-11-0359

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  17 in total

1.  Exploratory metabolomic study to identify blood-based biomarkers as a potential screen for colorectal cancer.

Authors:  Isaac Asante; Hua Pei; Eugene Zhou; Siyu Liu; Darryl Chui; EunJeong Yoo; David V Conti; Stan G Louie
Journal:  Mol Omics       Date:  2019-02-11

2.  Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study.

Authors:  Sajin Bae; Cornelia M Ulrich; Marian L Neuhouser; Olga Malysheva; Lynn B Bailey; Liren Xiao; Elissa C Brown; Kara L Cushing-Haugen; Yingye Zheng; Ting-Yuan David Cheng; Joshua W Miller; Ralph Green; Dorothy S Lane; Shirley A A Beresford; Marie A Caudill
Journal:  Cancer Res       Date:  2014-10-21       Impact factor: 12.701

3.  Associations between S-adenosylmethionine, S-adenosylhomocysteine, and colorectal adenoma risk are modified by sex.

Authors:  Martha J Shrubsole; Conrad Wagner; Xiangzhu Zhu; Lifang Hou; Lioudmila V Loukachevitch; Reid M Ness; Wei Zheng
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

4.  Alterations in folate-dependent one-carbon metabolism as colon cell transition from normal to cancerous.

Authors:  I Asante; D Chui; H Pei; E Zhou; C De Giovanni; D Conti; S Louie
Journal:  J Nutr Biochem       Date:  2019-03-12       Impact factor: 6.048

5.  Serum betaine but not choline is inversely associated with breast cancer risk: a case-control study in China.

Authors:  Yu-Feng Du; Fang-Yu Lin; Wei-Qing Long; Wei-Ping Luo; Bo Yan; Ming Xu; Xiong-Fei Mo; Cai-Xia Zhang
Journal:  Eur J Nutr       Date:  2016-02-20       Impact factor: 5.614

6.  Dietary B vitamin and methionine intakes and lung cancer risk among female never smokers in China.

Authors:  Yumie Takata; Qiuyin Cai; Alicia Beeghly-Fadiel; Honglan Li; Martha J Shrubsole; Bu-Tian Ji; Gong Yang; Wong-Ho Chow; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu
Journal:  Cancer Causes Control       Date:  2012-10-12       Impact factor: 2.506

7.  Prospective study of alcohol consumption and the risk of colorectal cancer before and after folic acid fortification in the United States.

Authors:  Hongmei Nan; Jung Eun Lee; Eric B Rimm; Charles S Fuchs; Edward L Giovannucci; Eunyoung Cho
Journal:  Ann Epidemiol       Date:  2013-05-29       Impact factor: 3.797

8.  Simultaneous quantitation of folates, flavins and B6 metabolites in human plasma by LC-MS/MS assay: Applications in colorectal cancer.

Authors:  Isaac Asante; Hua Pei; Eugene Zhou; Siyu Liu; Darryl Chui; EunJeong Yoo; Stan G Louie
Journal:  J Pharm Biomed Anal       Date:  2018-05-22       Impact factor: 3.935

9.  Serum Trimethylamine N-oxide, Carnitine, Choline, and Betaine in Relation to Colorectal Cancer Risk in the Alpha Tocopherol, Beta Carotene Cancer Prevention Study.

Authors:  Kristin A Guertin; Xinmin S Li; Barry I Graubard; Demetrius Albanes; Stephanie J Weinstein; James J Goedert; Zeneng Wang; Stanley L Hazen; Rashmi Sinha
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-11       Impact factor: 4.254

10.  Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies.

Authors:  Weixing Ding; Dong-Lei Zhou; Xun Jiang; Lie-Sheng Lu
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.